Intervention effect of kushenol F on ulcerative colitis mice
OBJECTIVE To investigate the intervention effect of kushenol F(KSC-F)on ulcerative colitis(UC)mice.METHODS Totally 30 male C57BL/6J mice were randomly divided into the normal group,model group,positive drug group(sulfasalazine,703 mg/kg),KSC-F 50 mg/kg group(KSC-F50 group),and KSC-F 100 mg/kg group(KSC-F100 group),with 6 mice in each group.Except for the normal group,the mice in the remaining groups were given 3%dextran sulfate sodium solution continuously for 7 days to induce UC model.Concurrently,administration groups received corresponding drug solution intragastrically,once a day,for 10 consecutive days.During the experiment,the changes in body weight and bowel movements of the mice were observed.Disease activity index scoring was performed after the last administration.The histopathological morphology of colonic tissue was examined.The levels of inflammatory factors in the serum and colon tissue were measured.Additionally,the mRNA expression of inflammatory factors,and the protein expressions of inflammation-related proteins[interleukin-1β(IL-1β),forkhead box O1(FOXO1),phosphoinositide 3-kinase(PI3K),phosphorylated PI3K(p-PI3K),p38 mitogen-activated protein kinase(p38 MAPK),phosphorylated p38 MAPK(p-p38 MPAK)and phosphorylated protein kinase B(p-Akt)]were determined in colonic tissue.RESULTS KSC-F could alleviate weight loss and colonic tissue damage in UC mice.KSC-F reduced the levels of IL-1β,IL-6,IL-8 and tumor necrosis factor-α(TNF-α)in serum,as well as IL-1β,IL-6,IL-17 and TNF-α in colonic tissue to varying degrees and increased the levels of IL-10 in both serum and colonic tissue(P＜0.05 or P＜0.01).Moreover,KSC-F decreased the expression levels of IL-1β,IL-17 and TNF-α mRNA,as well as p-PI3K,p-p38 MAPK,and p-Akt proteins in colonic tissue to varying degrees,and increased the expression levels of IL-10 mRNA and FOXO1 protein in colonic tissue(P＜0.05 or P＜0.01).CONCLUSIONS KSC-F effectively alleviates UC symptoms in mice by inhibiting PI3K,Akt and p38 MAPK activation,mitigating the release of pro-inflammatory factors such as IL-1β,IL-6,TNF-α,promoting the anti-inflammatory factor IL-10 secretion,and reducing inflammation-induced colonic tissue damage.
万方数据
维普
